SG Americas Securities
INBX

SG Americas Securities’s Inhibrx, Inc. Common Stock INBX Stock Holding History

SG Americas Securities’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,163
Closed -$286K – 3471
2023
Q1 		$286K Buy
15,163
+10,824
+249% +$252K ﹤0.01% 2152
2022
Q4 		$107K Sell
4,339
-1,820
-30% -$53.5K ﹤0.01% 2677
2022
Q3 		$111K Buy
+6,159
New +$111K ﹤0.01% 2792
2022
Q1 		– Sell
-5,975
Closed -$261K – 3681
2021
Q4 		$261K Sell
5,975
-4,696
-44% -$188K ﹤0.01% 2526
2021
Q3 		$355K Buy
+10,671
New +$325K ﹤0.01% 2791

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SG Americas Securities's INBX Position: Q2 2023 in Review

SG Americas Securities sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2023, closing a stake of 15,163 shares — an estimated $286K sold.

SG Americas Securities first reported a position in INBX in Q3 2021 and held it in 5 quarters. The position peaked at $355K in Q3 2021. 107 funds tracked by Wall St. Rank hold INBX as of Q2 2023.

  • SG Americas Securities reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • SG Americas Securities sold 15,163 Inhibrx, Inc. Common Stock shares in Q2 2023, an estimated $286K.
  • SG Americas Securities first reported a position in Inhibrx, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • SG Americas Securities's Inhibrx, Inc. Common Stock position peaked at $355K in Q3 2021.
  • 107 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2023.

Based on SG Americas Securities's 13F filing for Q2 2023, filed 10 Jul 2023.